International Murex Technologies Corp. said Friday that it hasraised $35 million in a private placement of 3.1 millioncommon shares priced at $11.25 per share.
The shares were offered to institutional investors in Europeand the Far East. The offering syndicate is a group led byDeacon Barclays de Zoete Wedd Ltd., which has an option tobuy 890,000 additional shares to cover overallotments.
Toronto, Canada-based Murex develops diagnostic tests forinfectious diseases and products for the blood bankingindustry.
Murex shares (AMEX:MXX) closed at $11.63, down 13 cents, onFriday. After the offering, Murex will have 13.8 million sharesoutstanding.
(c) 1997 American Health Consultants. All rights reserved.